|
|
|
Volumn 2 Suppl 4, Issue , 2004, Pages
|
|
Bortezomib in combination with other therapies for the treatment of multiple myeloma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
GLYCOPROTEIN P;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
PROTEASOME;
PROTEIN BCL 2;
PROTEINASE INHIBITOR;
PYRAZINE DERIVATIVE;
DRUG ANTAGONISM;
DRUG RESISTANCE;
HUMAN;
MULTIPLE MYELOMA;
PHASE 1 CLINICAL TRIAL;
PHYSIOLOGY;
REVIEW;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BORONIC ACIDS;
CLINICAL TRIALS, PHASE I AS TOPIC;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MULTIPLE MYELOMA;
NF-KAPPA B;
P-GLYCOPROTEIN;
PROTEASE INHIBITORS;
PROTEASOME ENDOPEPTIDASE COMPLEX;
PROTO-ONCOGENE PROTEINS C-BCL-2;
PYRAZINES;
|
|
EID: 70349897732
PISSN: 15401405
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (22)
|
